Medicine and Dentistry
Adenoviridae
25%
Androgen Receptor
37%
Assay
25%
Binding Site
12%
Bladder
12%
Bladder Cancer
37%
Bladder Cancer Cell Line
12%
Cancer Cell
12%
Caspase 3
12%
Cell Cycle
12%
Cell Killing
12%
Cells
12%
Combination Therapy
25%
Cytolysis
12%
Cytopathogenic Effect
12%
Cytotoxicity
25%
Development
12%
Enhancer Region
12%
In Vitro
12%
Indicator
12%
Lentivirus
25%
Luciferase
12%
Oncolytic Adenovirus
50%
P21
100%
Phosphotransferase Inhibitor
12%
Programmed Cell Death
12%
Promoter Region
37%
Prostate Stem Cell Antigen
12%
Receptor Binding
12%
Short Hairpin RNA
25%
Specific Tumor
12%
Tumor Cell
12%
Uroplakin 2
37%
Virus Particle
12%
Virus Replication
25%
Biochemistry, Genetics and Molecular Biology
Adenoviridae
25%
Androgen Receptor
37%
Apoptosis
12%
Binding Site
12%
Cancer Cell
12%
Caspase 3
12%
Cell Cycle
12%
Cell Killing
12%
Cytolysis
12%
Cytopathogenic Effect
12%
Cytotoxicity
25%
Development
12%
Electric Potential
25%
Enhancer Region
12%
Kinase
12%
Luciferase
12%
P21
100%
Promoter Region
37%
Virus Particle
12%
Virus Replication
25%
Western Blot
62%
Immunology and Microbiology
Adenoviridae
25%
Apoptosis
12%
Binding Site
12%
Bladder
50%
Bladder Cancer Cell Line
12%
Cancer Cell
12%
Cell Cycle
12%
Cell Killing
12%
Cells
12%
Cytolysis
12%
Cytopathic Effect
12%
Cytotoxicity
25%
Development
12%
Electric Potential
25%
Enhancer Region
12%
Lentivirus
50%
Oncolytic Adenovirus
50%
Promoter Region
37%
Prostate Stem Cell Antigen
12%
Receptor Binding
12%
Tumor Cell
12%
Viral Replication
25%
Virus Particle
12%
Neuroscience
Androgen Receptor
37%
Apoptosis
12%
Binding Site
12%
Caspase 3
12%
Cell Cycle
12%
Cell Killing
12%
Cytolysis
12%
Cytopathogenic Effect
12%
Cytotoxicity
25%
Enhancer Region
12%
In Vitro
12%
Kinase
12%
Luciferase
12%
Oncolytic Adenovirus
50%
Promoter Region
37%
Prostate Stem Cell Antigen
12%
Small Hairpin RNA
25%
Uroplakin 2
37%
Pharmacology, Toxicology and Pharmaceutical Science
Adenoviridae
25%
Androgen Receptor
37%
Binding Site
12%
Bladder Cancer
37%
Caspase 3
12%
Cytotoxicity
12%
Indicator
12%
Lentivirus
25%
Luciferase
12%
Oncolytic Adenovirus
50%
Phosphotransferase Inhibitor
12%
Prostate Stem Cell Antigen
12%
Short Hairpin RNA
25%
Uroplakin 2
37%